Tandem Diabetes Care
TNDM
69 hedge funds and large institutions have $170M invested in Tandem Diabetes Care in 2014 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 15 closing their positions.
69% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 13
47% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 15
11% more funds holding
Funds holding: 62 → 69 (+7)
19% less capital invested
Capital invested by funds: $210M → $170M (-$40.2M)
96% less call options, than puts
Call options by funds: $23K | Put options by funds: $536K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Apex Capital Management
Dayton,
Ohio
|
+$5.04M |
| 2 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$3.7M |
| 3 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$3.45M |
| 4 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
+$3.44M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$2.73M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$13.5M |
| 2 |
TCP
TAMRO Capital Partners
Alexandria,
Virginia
|
-$11.8M |
| 3 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$3.48M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$3.1M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$2.45M |
TNDM Hedge Fund Activity: Q3 2014 in Review
69 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q3 2014, worth a combined $170M — down 19% from $210M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new TNDM positions and 15 closed out — a net gain of 7 holders — while 22 added to existing stakes and 13 trimmed.
The largest buyer was Apex Capital Management, opening a new position worth an estimated $5.04M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $13.5M sold.
- 69 institutional investors held Tandem Diabetes Care (TNDM) as of Q3 2014, up from 62 in Q2 2014.
- Funds reported $170M of Tandem Diabetes Care stock for Q3 2014, down 19% quarter-over-quarter.
- 22 funds opened new Tandem Diabetes Care positions in Q3 2014 and 15 closed out, a net change of +7 holders.
- The largest Tandem Diabetes Care buyer in Q3 2014 was Apex Capital Management, an estimated $5.04M added.
- The largest Tandem Diabetes Care seller in Q3 2014 was JP Morgan Chase, an estimated $13.5M sold.
Based on aggregated 13F filings for Q3 2014.